Generic placeholder image

Current Drug Metabolism


ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Clinical Risk Management of Interactions Between Natural Products and Drugs

Author(s): Peter A.G.M. De Smet, Annemieke Floor-Schreudering, Marcel L. Bouvy and Michel Wensing

Volume 9, Issue 10, 2008

Page: [1055 - 1062] Pages: 8

DOI: 10.2174/138920008786927730

Price: $65


Clinical risk management offers a systematic approach to minimize healthcare-related risks by paying attention to: (1) risk identification and assessment; (2) development and execution of risk reduction strategies; (3) evaluation of risk reduction strategies. This paper reviews these key areas for the risk of interactions between natural products and drugs (NPDIs) to explore how the impact of these interactions on public health can be minimized. It argues that specific components of clinical risk management need to be evaluated, before adoption, and then actively implemented if proven valuable.

Keywords: Herb-drug interactions, risk management

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy